![Wolfram Dempke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Wolfram Dempke
Teknisk/Vetenskaplig/F&U Direktör på
CANTARGIA AB
Profil
Wolfram Dempke currently works at Cantargia AB, as Chief Medical Officer from 2025 and Ludwig-Maximilians-Universität München, as Professor.
Dr. Dempke received his doctorate degree from the University of London and doctorate degree from the University of Duisburg-Essen.
Aktiva positioner av Wolfram Dempke
| Företag | Position | Start |
|---|---|---|
| CANTARGIA AB | Teknisk/Vetenskaplig/F&U Direktör | 2025-10-02 |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Wolfram Dempkes utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
27
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Duisburg-Essen
 University of Duisburg-Essen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cantargia AB
 Cantargia AB Pharmaceuticals: MajorHealth Technology Creates and develops antibody therapeutics for the treatment of leukemia | Health Technology |
